| Ability Physical Therapy, Llc | |
|
2695 Northpark Dr, Suite 102, Lafayette, CO 80026-3177 | |
| (303) 926-1796 | |
| (303) 604-0424 |
| Full Name | Ability Physical Therapy, Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 2695 Northpark Dr, Lafayette, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124375779 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 10813 (Colorado) | Primary |
| Provider Name | Lucinda H Parham |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1871511311 PECOS PAC ID: 2062407935 Enrollment ID: I20040419001506 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Lindsey A Deneen |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1053460618 PECOS PAC ID: 9638144975 Enrollment ID: I20040830000882 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Patrick J Naylor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255501961 PECOS PAC ID: 8527090265 Enrollment ID: I20050902000225 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Katherine M Ferrington |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1396932620 PECOS PAC ID: 2365612579 Enrollment ID: I20110825000674 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Kurt R Roeser |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1700132180 PECOS PAC ID: 6608026422 Enrollment ID: I20121101000016 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Joel C Crandall |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1649525692 PECOS PAC ID: 0547552390 Enrollment ID: I20160714001467 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Rachel C Hidde |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1700330081 PECOS PAC ID: 6406134154 Enrollment ID: I20161031002004 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Carol C Passarelli |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376034702 PECOS PAC ID: 2264797513 Enrollment ID: I20180607001729 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Kelsey Wisinski |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1114416286 PECOS PAC ID: 8426303272 Enrollment ID: I20180619000941 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Alisyn Hummelberg |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568951317 PECOS PAC ID: 9931454477 Enrollment ID: I20180625000851 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Rachel E Moore |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699093336 PECOS PAC ID: 6800139130 Enrollment ID: I20190529003027 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Katherine Kennedy |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1184165870 PECOS PAC ID: 0547546517 Enrollment ID: I20190905000731 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Jordan E Allison |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1366841686 PECOS PAC ID: 2466783824 Enrollment ID: I20191016000890 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Abigail R Robson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255741443 PECOS PAC ID: 4880811637 Enrollment ID: I20200804001451 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Isaiah Faas |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1972112142 PECOS PAC ID: 6406272483 Enrollment ID: I20200820003353 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Tammy Joe |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1063177863 PECOS PAC ID: 6507258365 Enrollment ID: I20220128000576 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Jessie Mclaughlin |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1326616350 PECOS PAC ID: 8123410909 Enrollment ID: I20220128001188 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Randi S Steiner |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1285390161 PECOS PAC ID: 3577956325 Enrollment ID: I20220131001914 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Geordan Nunes |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407571219 PECOS PAC ID: 2961872882 Enrollment ID: I20230110000905 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Darlene Zerwekh Reardon |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073094223 PECOS PAC ID: 2567837271 Enrollment ID: I20230412000095 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Sarah Neumar |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1518425685 PECOS PAC ID: 1951776590 Enrollment ID: I20230412001540 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Brittney Feivor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710513106 PECOS PAC ID: 2961831458 Enrollment ID: I20230825003489 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Provider Name | Sydney Devoss |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1821873597 PECOS PAC ID: 2567807266 Enrollment ID: I20240305000309 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ability Physical Therapy, Llc 2695 Northpark Dr, Suite 102, Lafayette, CO 80026-3177 Ph: (303) 926-1796 | Ability Physical Therapy, Llc 2695 Northpark Dr, Suite 102, Lafayette, CO 80026-3177 Ph: (303) 926-1796 |
News Archive
A new study from the University of Georgia has shown that exposure to a now-banned flame retardant can alter the genetic code in sperm, leading to major health defects in children of exposed parents.
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Keele University School of Psychology in the UK will host the 5th Annual Meeting of the Alcohol Hangover Research Group, Thu 1st - Fri 2nd August 2013.
The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.
› Verified 5 days ago
Samantha Westfall, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2695 Northpark Dr Ste 102, Lafayette, CO 80026 Phone: 303-926-1796 | |
Brian J Williams, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Colorado Sports Physical Therapy, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 390 Empire Rd Ste 201, Lafayette, CO 80026 Phone: 410-279-0479 | |
Ms. Lindsey Ann Deneen, MSPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2695 Northpark Dr Ste 102, Lafayette, CO 80026 Phone: 303-926-1796 Fax: 303-604-0424 | |
Carol Hammer, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 329 Exempla Cir, Lafayette, CO 80026 Phone: 720-639-2200 | |
Tammy Joe, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2695 Northpark Dr Ste 102, Lafayette, CO 80026 Phone: 303-926-1796 | |
Dr. Steven Pochron, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1000 W South Boulder Rd, Lafayette, CO 80026 Phone: 303-415-4075 |